Key result
Aerobic exercise improves flow-mediated dilation by ~1.8 percentage points in type 2 diabetes.
Why the study?
The effect of exercise therapy on flow-mediated dilation in type 2 diabetes mellitus compared to non-diabetes patients with lifestyle-related diseases was unclear.
Does aerobic exercise therapy improve flow-mediated dilation differently in patients with type 2 diabetes compared to non-diabetes patients?
Cohort (n=16)
No
Does aerobic exercise therapy improve flow-mediated dilation differently in patients with type 2 diabetes compared to non-diabetes patients?
Regular aerobic exercise therapy effectively improves endothelial dysfunction in patients with type 2 diabetes, achieving cardiovascular benefits even when weight loss or improved glycemic control are absent.
Answers are grounded in this paper and cite their sources.
Aerobic exercise may improve endothelial function in type 2 diabetes independent of weight loss; hypothesis-generating and requires randomized trials before changing practice.
The aim of this study was to examine whether exercise therapy affected flow-mediated dilation (FMD) in the brachial artery differently in patients with type 2 diabetes mellitus (T2DM) and those with lifestyle-related diseases other than diabetes. The diabetes and non-diabetes groups included eight participants in each group. Aerobic exercises were performed at least twice a week for 40 minutes per session. All parameters were measured at the beginning and after 6 months of exercise therapy. FMD in the diabetes group was significantly improved by exercise therapy. In contrast, there was no significant increase in FMD in the non-diabetes group. The diabetes group did not show any significant reductions in waist circumference, body mass index (BMI), or HbA1c level, while waist circumference and BMI in the non-diabetes group were significantly reduced after exercise therapy. Our results demonstrated that endothelial dysfunction in T2DM was improved by exercise therapy, independent of weight-loss or glycemic control.
No takes yet. Share an insight, caveat, or question.
Igaki et al. (2017) conducted a cohort in Type 2 diabetes mellitus and lifestyle-related diseases (n=16). Aerobic exercise therapy vs. Non-diabetes patients undergoing the same aerobic exercise therapy was evaluated on Flow-mediated dilation (FMD) at 6 months (p=0.01). A 6-month aerobic exercise program improved flow-mediated dilation from 3.1% to 4.9% in patients with type 2 diabetes, independent of weight loss or glycemic control.
Synapse has enriched 10 related papers. Consider them for comparative context: